Target intelligence / Profile preview

Multiple Intracellular Pathways in Recipient Cells

Molecular classification
Other
01

Overview

Multiple Intracellular Pathways in Recipient Cells is a descriptive phrase used to characterize the broad and often complex signaling responses within a cell that has received external biological information, such as from extracellular vesicles (EVs), exosomes, or paracrine factors (Source: Molecular Cancer, 2020). It does not represent a single molecular target like a specific receptor or enzyme; instead, it encompasses various interconnected signal transduction networks, including the MAPK/ERK, PI3K/Akt, and JAK/STAT pathways, which collectively determine the cell's physiological response (Source: Nature Reviews Molecular Cell Biology). This terminology is frequently employed in the context of regenerative medicine and oncology to describe how complex biological products, like the mesenchymal stem cell (MSC) secretome, exert their effects by simultaneously modulating numerous cellular processes rather than hitting a single "lock-and-key" target (Source: Stem Cell Research & Therapy). Because it lacks a discrete molecular structure or a specific genetic locus, it is not classified as a canonical therapeutic target. Consequently, drugs or therapies associated with this concept typically exhibit pleiotropic effects, making the prediction of specific outcomes and safety profiles challenging in a clinical setting (Source: Journal of Cell Science).

Other names
Intracellular signaling cascadesDownstream signaling networksCellular signaling pathwaysRecipient cell signaling
02

Mechanism of action

Not applicable. This term refers to the broad downstream signaling effects of a stimulus rather than a specific drug-target interaction.

03

Biological functions

Signal transductionCellular communicationGene expression regulationCellular homeostasis
04

Disease associations

CancerInflammationRegenerative medicineAutoimmune disease
05

Safety considerations

Pleiotropic effects leading to systemic toxicityDifficulty in achieving therapeutic window due to multi-pathway involvementPotential for unintended activation of oncogenic pathways
06

Biomarkers

Phospho-ERK1/2Phospho-AktPhospho-STAT3NF-kappaB nuclear translocation

Beyond the preview

Go deeper on Multiple Intracellular Pathways in Recipient Cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple Intracellular Pathways in Recipient Cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call